Alar Pharmaceuticals Inc.

This early-stage study tested a new medicine called ALA-3000 in 37 adults whose depression did not get better with standard treatments. The main goal was to see if the drug is safe and how the body processes it. Researchers also looked for early signs that it might help lift depr…